Hallstein Auran eier aksjer i 2 selskaper.
- Selskap
- Privatpersoner
- Utenlandsk
Hallstein Auran
Norbit ASA
<0,1 %
Norbit Kabelpartner AS
100 %
Norbit Ems AS
100 %
Norbit Aptomar AS
100 %
Fenrits AS
100 %
Nomek Syd AS
100 %
Norbit Subsea AS
100 %
Norbit R&D AS
100 %
Tangen Næringsbygg AS
0,3 %
Proventure Seed III AS
0,4 %
Loopfront AS
26,6 %
Infotiles AS
19,4 %
Sonair AS
18,7 %
Enua AS
17,6 %
Cimon Medical AS
17,5 %
Cimon Medical AS
1,2 %
Defibrio AS
15,4 %
Tht Robotics Holdings AS
14,8 %
Cardboard AS
5,3 %
Kiip.app AS
4,4 %
Dr.dropin AS
0,3 %
Helseconnect AS
100 %
Dr.dropin Ip AS
100 %
Dr.dropin Spesialist AS
94,6 %
Dr.dropin Psykologi AS
81,1 %
Dr.dropin Bht AS
78,8 %
Dr.dropin Fysikalske AS
70,3 %
Sandvika Fysioterapi AS
100 %
Helseutdanning AS
66,7 %
Journalia AS
50 %
Loco Holdco 30 AS
44,4 %
Dr.dropin Bht AS
18,4 %
Dr.dropin Fysikalske AS
16,4 %
Sandvika Fysioterapi AS
100 %
Norbit ASA
0,2 %
Kongsberg Gruppen ASA
<0,1 %
KNB12 Ulsteinvik AS
100 %
KNB13 Brattvåg AS
100 %
Kongsberg Discovery AS
100 %
Neuver Maritime AS
100 %
Kongsberg Space AS
100 %
Kongsberg Norcontrol AS
100 %
Rygge 2 AS
100 %
Rygge Eiendom AS
100 %
Kta Naval Systems AS
50 %
Ksat Global AS
100 %
Jordobservasjon AS
33,3 %
Vake Holding AS
70 %
Vake AS
100 %
Kongsberg Maritime AS
100 %
Simrad AS
100 %
Massterly AS
50 %
Runde Miljøbygg AS
5,2 %
Åkp AS
1,2 %
Ålesund Kunnskapspark AS
100 %
Åkp Blue Innovation Arena AS
53,8 %
Rom & Tonik AS
9,4 %
Nordveggen AS
5 %
Createview AS
2,5 %
Zegeba AS
2,2 %
Effee AS
1,4 %
Effee Foundry AS
100 %
Effee Osr AS
100 %
Effee Australia AS
100 %
Corron AS
100 %
Corron Production AS
51 %
Effee AS
1,4 %
Recuro AS
1,1 %
Bagid AS
0,8 %
Såkorn 1 Midt AS
0,7 %
Ably Medical AS
6 %
Ably Production AS
100 %
Ably Medical AS
0,4 %
Corvus Energy Holding AS
0,7 %
Corvus Energy AS
100 %
Green Yacht AS
11,2 %
Hydrogen Viking AS
100 %
Corvus Energy Holding AS
<0,1 %
Kobben AS
0,2 %
Kobben Inkubator AS
100 %
Kobben Spark AS
100 %
Kobben Consulting AS
100 %
Sensocure AS
16,3 %
Mti Startup AS
9,5 %
Wionetic AS
8,3 %
Wittario AS
3,2 %
Wittario AS
1 %
Carbonworks Norway AS
100 %
Smartgroup AS
1,7 %
Mti Vekst AS
0,9 %
Windsim AS
22,1 %
Windsim AS
0,3 %
Nanocaps AS
11,6 %
Wittario AS
10,9 %
Wittario AS
1 %
Mia Health AS
8 %
Pt Pool AS
48,2 %
Vestfold Flyplassinvest AS
<0,1 %
Sandefjord Lufthavn AS
13,5 %
Torpveien 125 AS
100 %
Vestfold Flyplassinvest AS
<0,1 %
Storebrand ASA
<0,1 %
Storebrand Facilities AS
100 %
Storebrand Aif AS
100 %
Lysaker Park Eiendom AS
100 %
Skagen AS
100 %
Cubera Private Equity AS
100 %
Cubera Collection AS
100 %
Csv 2020 AS
33 %
Csv X AS
30 %
Csv Ix AS
26,3 %
Csv 2023 AS
21,7 %
Csv 2024 AS
21 %
Csv 2021 AS
20 %
Cpe IV AS
20 %
Csv Impact i AS
20 %
Csv 2022 AS
20 %
Welcome Workdays AS
45 %
Quantfolio AS
36,8 %
Quantfolio AS
<0,1 %
Storebrand Forsikring AS
100 %
Storebrand Bank ASA
100 %
Bankenes Id-Tjeneste AS
7,7 %
Verd Investering AS
0,9 %
Vatnestrøm Industribygg AS
25,3 %
Moland Biovarme AS
20,4 %
Elgtun AS
20,1 %
Agdir Drift AS
15,7 %
Stablecare AS
15,4 %
Panterra AS
9,4 %
K2 Gründerlab AS
6,4 %
Vipps Holding AS
0,2 %
Stø AS
100 %
Vipps Mobilepay AS
72,2 %
Sif II Gp AS
100 %
Storebrand Hjemmel AS
100 %
Storebrand Økern AS
100 %
Pensjonskontoregisteret AS
31,1 %
Norsk Pensjon AS
27 %
Nordic Credit Rating AS
4,8 %
Storebrand ASA
3,1 %
Losby Golfpark AS
0,1 %
Losby Golfpark AS
32,6 %
Falkor Holding ASA
83,2 %
K-Sim AS
100 %
Falkor AS
100 %
Futureon AS
89,8 %
Konciv AS
14 %
Kongsberg Innovasjon AS
12,5 %
Kongsberg Klyngen AS
100 %
Applied Autonomy AS
41,7 %
Profmof AS
33,5 %
Sunphade AS
28,7 %
Nordic Batteries AS
16,3 %
Bioenvision AS
13,9 %
Nostec AS
13 %
Skytale AS
12,1 %
Easyx AS
9,6 %
Upkip AS
9 %
Cartesian AS
7,6 %
Qbee AS
6,7 %
X-Tr AS
24,4 %
K F Holding AS
100 %
Vasshella Flexibles AS
13,3 %
Digital Norway AS
6,6 %
Digital Norway AS
27,2 %
Prophylix Pharma Holding AS
31,4 %
Prophylix AS
100 %
Calanus AS
8,4 %
Salgard AS
100 %
Zooca Calanus AS
100 %
Lyfstone AS
2,9 %
Lyfstone AS
1,2 %
Lyfstone Invest AS
1,1 %
Lytix Biopharma ASA
0,8 %
Lyfstone Invest AS
0,7 %
Amicoat AS
0,7 %
Peptide Patents AS
50 %
Pharma Holdings AS
0,4 %
Peptide Patents AS
50 %